- Home
- JEQ vs CNTB Comparison
JEQ vs CNTB Comparison
Compare JEQ & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JEQ
- CNTB
- Stock Information
- Founded
- JEQ 1990
- CNTB 2012
- Country
- JEQ United States
- CNTB United States
- Employees
- JEQ N/A
- CNTB N/A
- Industry
- JEQ Air Freight/Delivery Services
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- JEQ Consumer Discretionary
- CNTB Health Care
- Exchange
- JEQ Nasdaq
- CNTB Nasdaq
- Market Cap
- JEQ 99.8M
- CNTB 44.2M
- IPO Year
- JEQ N/A
- CNTB 2021
- Fundamental
- Price
- JEQ $7.50
- CNTB N/A
- Analyst Decision
- JEQ
- CNTB Strong Buy
- Analyst Count
- JEQ 0
- CNTB 2
- Target Price
- JEQ N/A
- CNTB $7.50
- AVG Volume (30 Days)
- JEQ 32.0K
- CNTB 103.1K
- Earning Date
- JEQ 01-01-0001
- CNTB 05-15-2025
- Dividend Yield
- JEQ 7.05%
- CNTB N/A
- EPS Growth
- JEQ N/A
- CNTB N/A
- EPS
- JEQ N/A
- CNTB N/A
- Revenue
- JEQ N/A
- CNTB $26,033,000.00
- Revenue This Year
- JEQ N/A
- CNTB N/A
- Revenue Next Year
- JEQ N/A
- CNTB N/A
- P/E Ratio
- JEQ N/A
- CNTB N/A
- Revenue Growth
- JEQ N/A
- CNTB N/A
- 52 Week Low
- JEQ $4.99
- CNTB $0.51
- 52 Week High
- JEQ $6.39
- CNTB $1.60
- Technical
- Relative Strength Index (RSI)
- JEQ 64.90
- CNTB 72.64
- Support Level
- JEQ $7.44
- CNTB $1.02
- Resistance Level
- JEQ $7.62
- CNTB $1.07
- Average True Range (ATR)
- JEQ 0.14
- CNTB 0.09
- MACD
- JEQ 0.02
- CNTB 0.01
- Stochastic Oscillator
- JEQ 60.22
- CNTB 91.19
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.